Applications of Boolean modelling to study and stratify dynamics of a complex disease

Interpretation of omics data is needed to form meaningful hypotheses about disease mechanisms. Pathway databases give an overview of disease-related processes, while mathematical models give qualitative and quantitative insights into their complexity. Similarly to pathway databases, mathematical models are stored and shared on dedicated platforms. Moreover, community-driven initiatives such as disease maps encode disease-specific mechanisms in both computable and diagrammatic form using dedicated tools for diagram biocuration and visualisation. To investigate the dynamic properties of complex disease mechanisms, computationally readable content can be used as a scaffold for building dynamic models in an automated fashion. The dynamic properties of a disease are extremely complex. Therefore, more research is required to better understand the complexity of molecular mechanisms, which may advance personalized medicine in the future. In this study, Parkinson’s disease (PD) is analyzed as an example of a complex disorder. PD is associated with complex genetic, environmental causes and comorbidities that need to be analysed in a systematic way to better understand the progression of different disease subtypes. Studying PD as a multifactorial disease requires deconvoluting the multiple and overlapping changes to identify the driving neurodegenerative mechanisms. Integrated systems analysis and modelling can enable us to study different aspects of a disease such as progression, diagnosis, and response to therapeutics. Therefore, more research is required to better understand the complexity of molecular mechanisms, which may advance personalized medicine in the future. Modelling such complex processes depends on the scope and it may vary depending on the nature of the process (e.g. signalling vs metabolic). Experimental design and the resulting data also influence model structure and analysis. Boolean modelling is proposed to analyse the complexity of PD mechanisms. Boolean models (BMs) are qualitative rather than quantitative and do not require detailed kinetic information such as Petri nets or Ordinary Differential equations (ODEs). Boolean modelling represents a logical formalism where available variables have binary values of one (ON) or zero (OFF), making it a plausible approach in cases where quantitative details and kinetic parameters 9 are not available. Boolean modelling is well validated in clinical and translational medicine research. In this project, the PD map was translated into BMs in an automated fashion using different methods. Therefore, the complexity of disease pathways can be analysed by simulating the effect of genomic burden on omics data. In order to make sure that BMs accurately represent the biological system, validation was performed by simulating models at different scales of complexity. The behaviour of the models was compared with expected behavior based on validated biological knowledge. The TCA cycle was used as an example of a well-studied simple network. Different scales of complex signalling networks were used including the Wnt-PI3k/AKT pathway, and T-cell differentiation models. As a result, matched and mismatched behaviours were identified, allowing the models to be modified to better represent disease mechanisms. The BMs were stratified by integrating omics data from multiple disease cohorts. The miRNA datasets from the Parkinson’s Progression Markers Initiative study (PPMI) were analysed. PPMI provides an important resource for the investigation of potential biomarkers and therapeutic targets for PD. Such stratification allowed studying disease heterogeneity and specific responses to molecular perturbations. The results can support research hypotheses, diagnose a condition, and maximize the benefit of a treatment. Furthermore, the challenges and limitations associated with Boolean modelling in general were discussed, as well as those specific to the current study. Based on the results, there are different ways to improve Boolean modelling applications. Modellers can perform exploratory investigations, gathering the associated information about the model from literature and data resources. The missing details can be inferred by integrating omics data, which identifies missing components and optimises model accuracy. Accurate and computable models improve the efficiency of simulations and the resulting analysis of their controllability. In parallel, the maintenance of model repositories and the sharing of models in easily interoperable formats are also important

Optimization ACE inhibition activity in hypertension based on random vector functional link and sine-cosine algorithm

Bioactive peptides from protein hydrolysates with antihypertensive properties have a great effect in health, which warrants their pharmaceutical use. Nevertheless, the process of their production may affect their efficacy. In this study, we investigate the inhibitory activities of various hydrolysates on angiotensin-converting enzyme (ACE) in relation to the chemical diversity of corresponding bioactive peptides. This depends on the enzyme specificity and process conditions used for the production of hydrolysates. In order to mitigate the uncontrolled chemical alteration in bioactive peptides, we propose a computational approach using the random vector functional link (RVFL) network based on the sine-cosine algorithm (SCA) to find optimal processing parameters, and to predict the ACE inhibition activity. The SCA is used to determine the optimal configuration of RVFL, improving the prediction performance. The experimental results show that the performance measures of the proposed model are better than the state-of-the-art methods

Applications of Boolean modeling to study the dynamics of a complex disease and therapeutics responses.

peer reviewedComputational modeling has emerged as a critical tool in investigating the complex molecular processes involved in biological systems and diseases. In this study, we apply Boolean modeling to uncover the molecular mechanisms underlying Parkinson's disease (PD), one of the most prevalent neurodegenerative disorders. Our approach is based on the PD-map, a comprehensive molecular interaction diagram that captures the key mechanisms involved in the initiation and progression of PD. Using Boolean modeling, we aim to gain a deeper understanding of the disease dynamics, identify potential drug targets, and simulate the response to treatments. Our analysis demonstrates the effectiveness of this approach in uncovering the intricacies of PD. Our results confirm existing knowledge about the disease and provide valuable insights into the underlying mechanisms, ultimately suggesting potential targets for therapeutic intervention. Moreover, our approach allows us to parametrize the models based on omics data for further disease stratification. Our study highlights the value of computational modeling in advancing our understanding of complex biological systems and diseases, emphasizing the importance of continued research in this field. Furthermore, our findings have potential implications for the development of novel therapies for PD, which is a pressing public health concern. Overall, this study represents a significant step forward in the application of computational modeling to the investigation of neurodegenerative diseases, and underscores the power of interdisciplinary approaches in tackling challenging biomedical problems

Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches

IntroductionThe COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. MethodsExtensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors.ResultsResults revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19. DiscussionThe key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies

Boolean modelling as a logic-based dynamic approach in systems medicine

International audienceMolecular mechanisms of health and disease are often represented as systems biology diagrams, and the coverage of such representation constantly increases. These static diagrams can be transformed into dynamic models, allowing for in silico simulations and predictions. Boolean modelling is an approach based on an abstract representation of the system. It emphasises the qualitative modelling of biological systems in which each biomolecule can take two possible values: zero for absent or inactive, one for present or active. Because of this approximation, Boolean modelling is applicable to large diagrams, allowing to capture their dynamic properties. We review Boolean models of disease mechanisms and compare a range of methods and tools used for analysis processes. We explain the methodology of Boolean analysis focusing on its application in disease modelling. Finally, we discuss its practical application in analysing signal transduction and gene regulatory pathways in health and disease

A versatile and interoperable computational framework for the analysis and modeling of COVID-19 disease mechanisms

The COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. Community-driven and highly interdisciplinary, the project is collaborative and supports community standards, open access, and the FAIR data principles. The coordination of community work allowed for an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework links key molecules highlighted from broad omics data analysis and computational modeling to dysregulated pathways in a cell-, tissue- or patient-specific manner. We also employ text mining and AI-assisted analysis to identify potential drugs and drug targets and use topological analysis to reveal interesting structural features of the map. The proposed framework is versatile and expandable, offering a significant upgrade in the arsenal used to understand virus-host interactions and other complex pathologies

DataSheet_2_Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.pdf

IntroductionThe COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. MethodsExtensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors.ResultsResults revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19. DiscussionThe key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies.</p

DataSheet_1_Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.xlsx

IntroductionThe COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. MethodsExtensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors.ResultsResults revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19. DiscussionThe key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies.</p